$10.26
00.00%
Last update: 4:00 PM
15 minutes delayed
TrueBlue
TBINYSE
TrueBlue (NYSE:TBI) Stock, Analyst Ratings, Price Targets, Forecasts
TrueBlue Inc has a consensus price target of $13 based on the ratings of 2 analysts. The high is $13 issued by BMO Capital on June 17, 2024. The low is $13 issued by BMO Capital on June 17, 2024. The 3 most-recent analyst ratings were released by BMO Capital, BMO Capital, and Baird on June 17, 2024, May 8, 2024, and May 7, 2024, respectively. With an average price target of $13 between BMO Capital, BMO Capital, and Baird, there's an implied 26.71% upside for TrueBlue Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Baird
1calculated from analyst ratings
Analyst Ratings for TrueBlue
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/17/2024 | Buy Now | 26.71% | BMO Capital | Jeffrey Silber | $13 → $13 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | 26.71% | BMO Capital | Jeffrey Silber | $15 → $13 | Maintains | Outperform | Get Alert |
| 05/07/2024 | Buy Now | 26.71% | Baird | Mark Marcon | $14 → $13 | Maintains | Outperform | Get Alert |
| 07/26/2023 | Buy Now | 94.93% | BMO Capital | Jeffrey Silber | $21 → $20 | Maintains | Outperform | Get Alert |
| 05/22/2023 | Buy Now | 94.93% | BMO Capital | Jeffrey Silber | $18 → $20 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/26/2023 | Buy Now | 75.44% | BMO Capital | Jeffrey Silber | $20 → $18 | Maintains | Market Perform | Get Alert |
| 04/25/2023 | Buy Now | 94.93% | Baird | Mark Marcon | $21 → $20 | Maintains | Outperform | Get Alert |
| 07/27/2022 | Buy Now | 104.68% | BMO Capital | Jeffrey Silber | $18 → $21 | Maintains | Market Perform | Get Alert |
| 07/26/2022 | Buy Now | 172.9% | Baird | Mark Marcon | $36 → $28 | Maintains | Outperform | Get Alert |
| 05/26/2022 | Buy Now | 94.93% | BMO Capital | Jeffrey Silber | → $20 | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for TrueBlue (TBI) stock?
The latest price target for TrueBlue (NYSE:TBI) was reported by BMO Capital on June 17, 2024. The analyst firm set a price target for $13.00 expecting TBI to rise to within 12 months (a possible 26.71% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TrueBlue (TBI)?
The latest analyst rating for TrueBlue (NYSE:TBI) was provided by BMO Capital, and TrueBlue maintained their outperform rating.
When was the last upgrade for TrueBlue (TBI)?
The last upgrade for TrueBlue Inc happened on May 22, 2023 when BMO Capital raised their price target to $20. BMO Capital previously had a market perform for TrueBlue Inc.
When was the last downgrade for TrueBlue (TBI)?
The last downgrade for TrueBlue Inc happened on May 26, 2022 when BMO Capital changed their price target from N/A to $20 for TrueBlue Inc.
When is the next analyst rating going to be posted or updated for TrueBlue (TBI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TrueBlue, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TrueBlue was filed on June 17, 2024 so you should expect the next rating to be made available sometime around June 17, 2025.
Is the Analyst Rating TrueBlue (TBI) correct?
While ratings are subjective and will change, the latest TrueBlue (TBI) rating was a maintained with a price target of $13.00 to $13.00. The current price TrueBlue (TBI) is trading at is $10.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.